Supreme Court Declines To Hear Benicar Patent Suit
This article was originally published in Scrip
Executive Summary
The US Supreme Court has refused to hear arguments in appeals brought by Mylan Pharmaceuticals Inc. and Daiichi Sankyo Co. Ltd. in lawsuits against Apotex Inc., which is seeking to market a generic version of Benicar (olmesartan) in the US.